U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. Reports, Manuals, & Forms
  4. Reports
  5. Economic Impact Analyses of FDA Regulations
  6. Summary: Antimicrobial Animal Drug Sales and Distribution Reporting (Final Rule)
  1. Economic Impact Analyses of FDA Regulations

Summary: Antimicrobial Animal Drug Sales and Distribution Reporting (Final Rule)

The Food and Drug Administration (FDA or we) is issuing a final rule to require that the sponsor of each approved or conditionally approved new animal drug product that contains an antimicrobial active ingredient submit an annual report to us on the amount of each such ingredient in the drug product that is sold or distributed for use in food-producing animals, including information on any distributor-labeled product. This final rule codifies the reporting requirements established in section 105 of the Animal Drug User Fee Amendments of 2008 (ADUFA). The final rule also includes an additional reporting provision intended to enhance our understanding of antimicrobial new animal drug sales intended for use in specific food-producing animal species and the relationship between such sales and antimicrobial resistance.

Regulatory Impact Analysis

Antimicrobial Animal Drug Sales and Distribution Reporting; Final Rule (PDF - 141KB)

Federal Register: 81 FR 29129, May 11, 2016

Docket: FDA-2012-N-0447, 0910-AG45

   

Back to Top